Use of inhibitors of the degradation of p27, in particular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4045 (2006.01) A61K 31/405 (2006.01) A61P 35/00 (2006.01) C07D 519/00 (2006.01) C07D 519/04 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2679435

The present invention relates to the use of particular macrocycles that are inhibitors of the proteasomic degradation of p27, in particular Argyrin and derivatives thereof, preferably Argyrin A, for the treatment of proliferative diseases, such as cancer, as well as the derivatization of said macrocycles.

La présente invention concerne l'utilisation de macrocycles particuliers qui sont des inhibiteurs de la dégradation protéasomique de p27, en particulier l'argyrine et ses dérivés, de préférence l'argyrine A, pour le traitement de maladies à évolution chronique, telles que le cancer. Elle concerne en outre la dérivatisation desdits macrocycles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of inhibitors of the degradation of p27, in particular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of inhibitors of the degradation of p27, in particular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the degradation of p27, in particular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1887926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.